23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.
NEW THIS YEAR: POSTER SESSION AND AWARDS
We invite students, residents, fellows, and faculty (less than 5 years from completing their training) to submit abstracts on basic science, translational research, or clinical research in breast cancer.
To submit an abstract for consideration, please send the following by January 6, 2025, to lucia.tono-ramirez@tuhs.temple.edu:
- One–page abstract (maximum 500 words), please structure your abstract as follows: Title, Background/Introduction, Objectives, Methods, Results and Conclusions
- In the abstract, please specify the name, credential, affiliation and e-mail of the person that will be presenting the poster. Priority will be given to early abstract submissions. Notifications of abstracts selected will be done by email.
PROGRAM DATE:
Thursday, January 30, 2025
TIMES:
5:45–7:00 pm EST Check-In, Reception and Poster Session
(Buffet opens at 6:30)
7:00–9:00 pm EST CME & Dinner
LOCATION:
Philadelphia Marriott Old City
One Dock Street
Philadelphia, PA 19106
LEARNING OBJECTIVES:
- Analyze the advances in the management of breast cancer and premalignant breast disease and when clinically relevant:
- Integrate new findings into the management of these patients.
- Apply new strategies for optimizing existing treatments into the management of these patients.
- Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.
PROGRAM DIRECTOR & FACULTY:
Angela Jain, MD
Asssociate Professor, Department of Hematology/Oncology;
Interim Chief, Division of Breast Medical Oncology;
Chief, Division of Gynecologic Medical Oncology;
Clinical Director, GYN/Well Women's Health Clinical Service Line;
Fox Chase Cancer Center
FACULTY:
Fox Chase Cancer Center
Melissa McShane, MD
Assistant Professor, Department of Hematology/Oncology;
Associate Program Director,
Hematology/Oncology Fellowship Training Program
Rebecca M. Shulman, MD
Assistant Professor, Department of Radiation Oncology
Austin D. Williams, MD, MSEd, FACS
Assistant Professor, Department of Surgical Oncology
PENN MEDICINE’S ABRAMSON CANCER CENTER:
Rachel C. Jankowitz, MD
Director, Rena Rowan Breast Center
Section Chief, Breast Cancer, Hematology-Oncology
Associate Professor of Clinical Medicine (Hematology-Oncology)
Hayley M. Knollman, MD
Assistant Professor of Clinical Medicine
(Hematology-Oncology)
PLANNING COMMITTEE:
Michael Seidman, MD
Professor, Department of Hematology/Oncology
Fox Chase Cancer Center
INTENDED AUDIENCE:
The program is designed for medical, surgical, and radiation oncologists; gynecologists; radiologists; fellows; residents; medical
school students; advanced practice providers; nurses; and healthcare professionals involved in the treatment of patients with breast cancer.
ACCREDITATION STATEMENT:
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
DESIGNATION STATEMENT:
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 2 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.
INQUIRIES:
Lucía Tono, PhD, MEd
215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu